Lynda Charters

Educating patients about the importance of consistent care is key.

Edward S. Wygonik, OD, and Kurt Moody, OD, presented data looking at in-practice assessments of the Acuvue Oasys 1-Day Max multifocal and spherical contact lenses during AAOpt 2023.

TearCare provides significant improvements in dry eye signs and symptoms, superior to Restasis in tear film break-up time improvements.

Collaboration between ophthalmologists, optometrists can boost early detection.

Qlosi (Orasis Pharmaceuticals) approved to treat presbyopia.

The International Agency for the Prevention of Blindness urges employers to prioritize eye health, aiming to enhance well-being, safety, and productivity.

The Contact Lens Institute (CLI) and The Vision Council published a collaborative effort titled “The Culture Calculation: Data-Backed Behaviors for Contact Lens Success.” This latest publication is part of the “See Tomorrow” research series.

The Centre for Ocular Research & Education (CORE) has expanded the number of presentations scheduled for the American Academy of Optometry 2023 annual meeting in New Orleans.

Bausch + Lomb is gearing up for the American Academy of Optometry (AAOpt) annual meeting, which is poised to convene in New Orleans from Oct. 11-14, 2023.

World Sight Day is on Thursday, October 12, 2023, and this year’s spotlight is focusing the world’s attention on the importance of eye care in the workplace.

The American Academy of Optometry recently announced the recipients of this year’s Garland W. Clay award.

Patients with HTG had significantly fewer mtDNA copies per nuclear DNA.

Save the dates: October 11-14, 2023.

Documenting the visual effects and simplifying visual life.

Knowing the approach to each step of ocular management can optimize patient vision.

The investigators explained that the platform delivers energy that differentially heats the tissue by the impedance of the electromagnetic current.

The investigators explored the effects of the following covariates on development of AMD: sex, ethnicity, smoking history, fluoxetine use, obesity, diabetes mellitus, and hypertension.

Results from a study have found that patients who wear scleral contact lenses have a slight increase in IOP.

Data from the 30 month GALE extension study indicated that continuous treatment with pegcetacoplan injection showed increasing beneficial effects over that timeframe in patients with geographic atrophy (GA).

A recent study found that the use of low-dose atropine drops is ineffective in slowing pediatric myopia progression, contradicting a previous study.

A single, consistent modality leads to better geographic atrophy tracking.

A recent study demonstrates the safety and efficacy of treating eyes with cross-linking after keratoconus relapses following keratoplasty.

Investigators set out to evaluate how well an AI system works when integrated into a handheld smartphone-based retinal camera to screen patients for DR using 1 retinal image in each eye.

The use of topical insulin eye drops led to a successful resolution of PEDs in 9 of 11 cases in the study.

While these injections are the standard treatment for this patient population, the investigators found a subgroup of patients who had severe visual loss between 2 consecutive intravitreal injections.

Researchers investigated the relationship between visual functioning measured using the National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25) and mortality in patients with various stages of AMD.

These findings demonstrate the exact association between high myopia and changes in the ocular blood flow, which heretofore had not been established.

This 3-pronged approach for nutritional intervention to help maintain dry eye disease is in addition to a recommended dietary intake of daily oily fish.

Over the past decade the progress in retinal disease treatments has exploded with increased numbers of approved pharmaceutical compounds, resulting in more options for treating retinal disease with intravitreal agents and more are in the pipeline.